Over the past several years, stem cell research has experienced a significant upswing, evidenced not just by activity in the lab and clinic but also by investments industrywide. And this boom is on track to continue growing, spurred in large part by in vitro stem cell research that’s driving new precision approaches in tissue engineering, cancer immunotherapies, neurological and endocrine diseases, and much more.

But amid this surge of activity and promise, challenges remain in making stem cell therapies production-ready for clinical research and market. This playbook taps leading industry experts to explain the changing landscape of stem cell research and how to overcome the pitfalls and optimize the promise of these therapies. After reading the playbook, you’ll be better positioned for commercial success and will understand how to:

• Keep cultures thriving for better cell quality
• Build the right microenvironment
• Break through expansion barriers with scale-up strategies

​